Finigan Paul M 4
4 · CURAGEN CORP · Filed Sep 25, 2009
Insider Transaction Report
Form 4
CURAGEN CORPCRGN
Finigan Paul M
Former EVP & General Counsel
Transactions
- Sale
Common Stock
2009-09-23$1.38/sh−300$414→ 132,719 total - Sale
Common Stock
2009-09-23−108,374→ 121,119 total - Sale
Common Stock
2009-09-24$1.35/sh−2,750$3,713→ 118,369 total - Sale
Common Stock
2009-09-24$1.33/sh−10,400$13,832→ 107,969 total - Sale
Common Stock
2009-09-23$1.37/sh−11,600$15,892→ 121,119 total - Exercise/Conversion
Common Stock
2009-09-23$0.69/sh+108,374$74,778→ 229,493 total - Sale
Common Stock
2009-09-24$1.34/sh−38,700$51,858→ 69,269 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2009-09-23−108,374→ 180,626 totalExercise: $0.69Exp: 2018-01-24→ Employee Stock Option (Right to Buy) (108,374 underlying)
Footnotes (2)
- [F1]Multiple sales were transacted on September 23, 2009 at a sale price ranging from $1.35 to $1.36 for a total of 108,374 shares sold.
- [F2]The option vested 25% on January 24, 2009 and 6.25% quarterly thereafter until January 24, 2012